These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 10762455)

  • 21. IgG reactivity to phospholipid-bound beta(2)-glycoprotein I is the main determinant of the fraction of lupus anticoagulant activity quenched by addition of hexagonal (II) phase phospholipid in patients with the clinical suspicion of antiphospholipid-antibody syndrome.
    Safa O; Crippa L; Della Valle P; Sabbadini MG; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Sep; 84(9):829-38. PubMed ID: 10477458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis.
    Matsuura E; Kobayashi K; Tabuchi M; Lopez LR
    Prog Lipid Res; 2006 Nov; 45(6):466-86. PubMed ID: 16790279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies.
    Ambrozic A; Cucnik S; Tomsic N; Urbanija J; Lokar M; Babnik B; Rozman B; Iglic A; Kralj-Iglic V
    Autoimmun Rev; 2006 Nov; 6(1):10-5. PubMed ID: 17110310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidized LDL/beta2-glycoprotein I complexes: new aspects in atherosclerosis.
    Matsuura E; Kobayashi K; Inoue K; Lopez LR; Shoenfeld Y
    Lupus; 2005; 14(9):736-41. PubMed ID: 16218478
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to prothrombin in antiphospholipid syndrome and inflammatory disorders.
    Guerin J; Smith O; White B; Sweetman G; Feighery C; Jackson J
    Br J Haematol; 1998 Sep; 102(4):896-902. PubMed ID: 9734636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating autoantibodies recognizing peroxidase-oxidized low density lipoprotein. Evidence for new antigenic epitopes formed in vivo independently from lipid peroxidation.
    Seccia M; Albano E; Maggi E; Bellomo G
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):134-40. PubMed ID: 9012648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to adult human endothelial cells cross-react with oxidized low-density lipoprotein and beta 2-glycoprotein I (beta 2-GPI) in systemic lupus erythematosus.
    Wu R; Svenungsson E; Gunnarsson I; Haegerstrand-Gillis C; Andersson B; Lundberg I; Elinder LS; Frostegård J
    Clin Exp Immunol; 1999 Mar; 115(3):561-6. PubMed ID: 10193434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial.
    Fraley AE; Schwartz GG; Olsson AG; Kinlay S; Szarek M; Rifai N; Libby P; Ganz P; Witztum JL; Tsimikas S;
    J Am Coll Cardiol; 2009 Jun; 53(23):2186-96. PubMed ID: 19497447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atherosclerosis.
    Nilsson J; Fredrikson GN
    Autoimmunity; 2004 Jun; 37(4):351-5. PubMed ID: 15518058
    [No Abstract]   [Full Text] [Related]  

  • 30. Antiphospholipid antibodies in arterial thrombosis.
    Koike T
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of phospholipids on the formation of immune complexes between autoantibodies and beta2-glycoprotein I or prothrombin.
    Bevers EM; Zwaal RF; Willems GM
    Clin Immunol; 2004 Aug; 112(2):150-60. PubMed ID: 15240158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Analysis of specificity of antiphospholipid antibodies with the use of monoclonal antibodies to phospholipids].
    Dons'koĭ BV; Chernyshov VP
    Ukr Biokhim Zh (1999); 2005; 77(6):109-15. PubMed ID: 19618752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to oxidised LDL.
    Vaarala O
    Lupus; 2000; 9(3):202-5. PubMed ID: 10805488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
    Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
    Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utilization of dilute Russell's viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids.
    Pengo V; Balestrieri G; Tincani A; Spatola L; Biasiolo A; Brocco T
    Thromb Haemost; 1997 Jan; 77(1):123-6. PubMed ID: 9031461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
    Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiphospholipid antibodies: more than just a disease marker?
    Mackworth-Young C
    Immunol Today; 1990 Feb; 11(2):60-5. PubMed ID: 2185781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.
    Dunér P; To F; Alm R; Gonçalves I; Fredrikson GN; Hedblad B; Berglund G; Nilsson J; Bengtsson E
    J Intern Med; 2009 May; 265(5):593-603. PubMed ID: 19226376
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinguished effects of antiphospholipid antibodies and anti-oxidized LDL antibodies on oxidized LDL uptake by macrophages.
    Kobayashi K; Tada K; Itabe H; Ueno T; Liu PH; Tsutsumi A; Kuwana M; Yasuda T; Shoenfeld Y; de Groot PG; Matsuura E
    Lupus; 2007; 16(12):929-38. PubMed ID: 18042586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxidized low-density lipoprotein as a risk factor of thrombosis in antiphospholipid syndrome.
    Matsuura E; Kobayashi K; Koike T; Shoenfeld Y; Khamashta MA; Hughes GR
    Lupus; 2003; 12(7):550-4. PubMed ID: 12892397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.